Fitness Trends
Pertuzumab Market

Publié sur 20 June 2019 dans “Santé & Fitness”, langue – English. 3 pages.

Description de la publication:

Pertuzumab is a recombinant monoclonal antibody that acts as an antineoplastic agent, which targets the human epidermal growth factor receptor 2 protein known as HER2. Plus

Lire

Autres publications de “Fitness Trends”

Voir toutes les publications

Fitness Trends Pertuzumab Market

Autres publications de “Fitness Trends”

Magazines connexes

Fitness Trends
Pertuzumab Market